Oseltamivir orally disintegrating tablets

Product Name :
Oseltamivir orally disintegrating tablets

Search keywords :
Oseltamivir

drugId :
null

Target Vo:
Neuraminidase

Target Vo Short Name :
NA

Moa_Name:
Neuraminidase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Hefei Industrial Pharmaceutical Co Ltd

Active Company_Name :
Hefei Industrial Pharmaceutical Co Ltd

Active Indication_Name:
Influenza A virus infections

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PDCD4 Rabbit mAb Purity & Documentation
Tremelimumab MedChemExpress
BRG1 Antibody: BRG1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 185 kDa, targeting to BRG1. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts